053030.KQ
BINEX Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 6,080.00
−0.33%Year over year
Reported trailing growth
- Revenue
- +2.7%
- EBITDA
- —
- EBIT
- —
- EPS
- -54.7%
- Free cash flow
- +18.5%
- Operating cash flow
- +108.2%
Forward estimates
Based on analyst estimates
- Revenue
- +5.8%
- EBITDA
- +395.6%
- EPS
- +110.4%
Three-year CAGR
- Revenue
- +2.4%
- EBITDA
- -28.5%
- EBIT
- +85.3%
- Net income
- +90.8%
- EPS
- +91.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026